Market Analysis 

The global aortic valve market was valued at USD 6,454.91 million in 2018 and is likely to grow at an 11.1% CAGR between 2025- 2034, as per the recent report by Market Research Future (MRFR). An aortic valve is implanted in the heart surgically for replacing a valve that has damaged owing to heart valve diseases like atresia, regurgitation, and stenosis. Replacing the damaged valves using prosthetic heart valves will help in reducing the mortality and morbidity related to aortic valve disorders. Biological and mechanical valves are the two types of aortic valves that are used in both open surgery and minimally invasive surgery. 

Various factors are adding to the global aortic valve market growth. Such factors, according to the new MRFR report, include favorable government initiatives to create awareness about valve replacement surgeries, burgeoning demand for minimally invasive surgeries, and rising prevalence of valvular diseases like aortic regurgitation and aortic stenosis. Additional factors adding market growth include rising product approvals, the launch of innovative & advanced products, and rising geriatric population.

On the contrary, changing regulatory landscapes and product recalls are factors that may limit the global aortic valve market growth over the forecast period. 

Market Segmentation

The MRFR report offers an inclusive segmental analysis of the global aortic valve market report based on end user, surgery, and type of valve. 

By valve type, the global aortic valve market is segmented into biological and mechanical. Of these, the mechanical valve segment will lead the market over the forecast period for its increasing use in replacement procedures. On the other hand, the biological valves segment will grow at a fast pace over the forecast period for growing awareness about the different benefits of using biological valves in the replacement procedure. 

By surgery type, the global aortic valve market is segmented into open surgery and minimally invasive surgery. The minimally invasive surgery segment is again segmented into trans-subclavian, transapical, transaortic implantation, and transfemoral. Of these, the minimally invasive surgery segment will dominate the market over the forecast period for faster recovery, less pain, and shorter hospital stay in comparison to open-heart surgery. 

By end users, the global aortic valve market is segmented into ambulatory surgery centers and hospitals. Among these, hospitals are likely to command the largest share in the aortic valve market over the forecast period. 

Regional Analysis

Based on the region, the global aortic valve market report covers the recent trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will command the largest share in the market over the forecast period. Increasing cases of cardiovascular diseases and the presence of top market players in the region are adding market growth in the region. 

The global aortic valve market in Europe is predicted to have the second-largest share over the forecast period. Increasing prevalence of heart disease and growing support to control cardiovascular diseases from regulatory authorities are adding market growth in the region. 

The global aortic valve market in the APAC region is likely to grow at a fast pace over the forecast period. Changing lifestyles in India, rising geriatric population, and increasing healthcare expenditure are adding market growth in the region. 

The global aortic valve market in the MEA is predicted to have the smallest share over the forecast period for limited exposure to advanced solutions and limited healthcare infrastructure. 

Key Players

Eminent players profiled in the global aortic valve market report include TTK HealthCare (India), JenaValve (US), Colibri Heart Valve (US), Biotronik (Germany), CryoLife (US), Edwards Lifesciences Corporation (US), LivaNova PLC (UK), Abbott Laboratories (US), Medtronic(US), and Boston Scientific Corporation (US).